Psychedelics Today, Author at PsyNews.com

Home Authors Posts by admin

2161 POSTS 0 COMMENTS

https://psynews.com

Exploring the Fungal Kingdom: Cultivation, Connection, and the Potential of Permaculture

Pα+ Psychedelic Bulletin #169: Brin Backs Soneira, But Patent Questions Loom...

Psychedelics in Palliative Care: Screening, Safety Measures, and Experiences With the...

When Data Meets Doubt: Investigating the FDA Panel’s Rejection of MDMA

Psychedelic Research: The Current Landscape and Future Directions

Understanding Bad Trips: The Power and Potential of Adverse Psychedelic Experiences

Pα+ Psychedelic Bulletin #168:

Ecopsychology, Plant Dietas, and Plant Consciousness: Building a Relationship with Nature

Women’s Health and Psychedelics – New Insights

Regenerative Business in Psychedelics: A Sustainable Path Forward

1...121314...217 Page 13 of 217

Can Legalization Serve the Greater Good? The Ethical Challenges of Psychedelic...

From Fringe to Focus: APA’s American Journal of Psychiatry Publishes Special...

Natural Medicine Advisory Bulletin 15: A Duplicitous December

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin